N
Google TrendLAMINE YAMAL (2000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:lamine yamal2000+abdulrahman alfozan500+pope francis500+olise500+delaware vs middle tennessee prediction500+bayern de múnich200+gme1000+flashscore200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Cardiovascular and Renal" (30 stories)

Top Headline Story

Cardiovascular–kidney–metabolic syndrome as a mitochondrial systems disorder
Lead StoryNaturegeneral
Sep 24

Cardiovascular–kidney–metabolic syndrome as a mitochondrial systems disorder

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90NGR3NUREbm1nVGZiNWd4dFp0dGh6YXp5bXkyNTA4QmNvTTBnTVVFdVZSbjdSMllaT2RRbE51ZGtLUVBPVW5ITGhFMmJ5c2U1bURTdXdseGNvenRDaXhZ?oc=5" target="_blank">Cardiovascular–kidney–metabolic syndrome as a mitochondrial systems disorder</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+19m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

Filter stories
500+29m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

Filter stories
500+29m ago

pope francis

The Myth of St. Francis

Filter stories
500+29m ago

olise

Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League

Filter stories

Search Results for "Cardiovascular and Renal"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors
Frontiersgeneral

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOcTllWWZyQXJUVjNwOHNGdGJfam16X2xQd1NwRGo3UU0zNTJlbXRRNGppeVVRdGJQbkoxSXFpRlZHWnF5M0NqcV9LNmxLalM4UzlZV3c0QzB1YkV0OVBoOVdHbWIxeFdHRV9TMmpOSm9iUDlpcmFXX1ZXSTRybm8yQ1lueTMxTEFvXzZjYmFTQ2RVXzBjdmJtTHgtZXBfUWRILWc?oc=5" target="_blank">Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes
Renal and Urology Newsgeneral

SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQN3dHZ3d1YlEyN2ZjSGYzc1ozaGt5eE5JMXpiQlhoOWtjN2RJR1plN3BPRzZ5QnBBNGp0REgzQmREUy1MajBlTVVpWEdlRzUxbjZjME9BX1kydkNaZVVNS3BqMG83ckEtdGkzbEhCdzQwZW1WWkZjLWRyWjg2MWptWVIzSTdwSGVmTnRiN2tuUGdodGN2ek8za19zaFFpUk1BVk1OQXhzaDVqblZiaG5Ec2o0R280QUZCNy1n?oc=5" target="_blank">SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryMore like this
Pregnancy complications linked to higher risk of cardiac and renal health conditions
BMJ Groupscience

Pregnancy complications linked to higher risk of cardiac and renal health conditions

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxNNkk2bWlzc1hxelYtdDV6aHk4Rll2aFJEZFhjcE83S01CNlJzYnctYUhoVlBEWU5HWldGMm9FS2MzN3FxQ2J0OGRCUi1ybFRZQWN3QkRtTXVrd1llVkdaZzlzMDBMeko5VkdGUjNtY1FHeGVHYlFoSEJzMDhBS21tTG5xY29fT1phUDdGeUdpbTN3WVpXUlRITS0xMGlYa1FBd3dfX0tCNHNYdw?oc=5" target="_blank">Pregnancy complications linked to higher risk of cardiac and renal health conditions</a>  <font color="#6f6f6f">BMJ Group</font>

Read Full StoryMore like this
First-ever guideline on cardiovascular-kidney-metabolic syndrome issued
www.heart.orggeneral

First-ever guideline on cardiovascular-kidney-metabolic syndrome issued

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPeVg1WE1rRlgzeEExNVdZbl91N2w0b3BIb1BKUW01NlgwM2RXQ3RvSHRlVWZiTVA1dmh5NmF2cHk3LXlEamstVjh2QWx0VFVIT2ZabXVSeTRfSENITUUwNkZVYloxckhlVERFM1BVaHVfSUtqOVNtYjFPYUhZTXc5SFU2WDhfT2NDMkdJLTM3NHdMTm85dm5hcWxNSzd0T05CTnNoUnZB?oc=5" target="_blank">First-ever guideline on cardiovascular-kidney-metabolic syndrome issued</a>  <font color="#6f6f6f">www.heart.org</font>

Read Full StoryMore like this
Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions
American Heart Association Journalsgeneral

Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5pTC0zOFB3MHlYV204bjdBaGZoWUFFZ0RaelZfTmdONkZRWFB2Mmp4UmlVUVFoQndOOVZDYjRuZUtZRzZEWFBSbVRvZ0FGSnU1dlcwbVRQQjkzczliVVdIVnVJdTZFMEVkNTlpRnAzMW01Sm40?oc=5" target="_blank">Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
First-Ever Guideline Addresses CKM Syndrome
American College of Cardiologygeneral

First-Ever Guideline Addresses CKM Syndrome

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNVDJOUWpWcXVFS3pYVWxFTlBxTzdNVGhBbE5URUpQeVpfaW9sQTVtcUdxazZDZ2hhUFRTQUxwc2xxaHNYQ25QeDBlMEFNS1VOQWxHbWdfV3o3WHdsN1NDdW85NDNSNkQtb1lrT1N5bV80bE5OWFhWRmFBZ0ZaUnVEUnZWUEhqdG80MVBOelNjMnRWeDY2M1VkZ2dPTHdwX3ZTZGN5OW5pdHU3MEIzWVBQZTFaYnc5QQ?oc=5" target="_blank">First-Ever Guideline Addresses CKM Syndrome</a>  <font color="#6f6f6f">American College of Cardiology</font>

Read Full StoryMore like this
ESC Issues First Joint Guidelines Bridging Cardiorenal Care
Medscapegeneral

ESC Issues First Joint Guidelines Bridging Cardiorenal Care

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPQXVkWWhNUFpreG5pWll1cjNPLWdfVVJuZ2s0djVXb0Npeko1V2pMR2ZxR0tOa0c3aU84QWdBZ05BU1NTbGl3ODNaQnNFeUxlRlhxRUZKLVl0QWFxZ2VVZnh0TVMxTUJmMkNFaVVHSU4xZktjcmZWem1JUVJ0SVFNWDBZR1Zzb2M4eTZCWUlNUHF3MlM0NE9FR05WTjhmWG1KaERKeWh3NW9YdEpwTWc?oc=5" target="_blank">ESC Issues First Joint Guidelines Bridging Cardiorenal Care</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Research connecting heart, kidneys, and metabolism leads to newly identified syndrome
Kaiser Permanente Division of Researchgeneral

Research connecting heart, kidneys, and metabolism leads to newly identified syndrome

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxNX0dTWkNwbURydEpzWDY5bEdsSEZfcjBlTkdGVzFnQXpFeGhCMVRmby00RkF5Tm1HSmgtaFJqOWhTaHJSekdqUE9mRkM3NTNydWw5dElZcllqa056TDlxQi1CUUFVU1Q0Ynptb2ExNXZud0xIQjFXUmZvNjFZNkZvcmh1aE8?oc=5" target="_blank">Research connecting heart, kidneys, and metabolism leads to newly identified syndrome</a>  <font color="#6f6f6f">Kaiser Permanente Division of Research</font>

Read Full StoryMore like this
Heart disease and kidney disease can fuel each other. New guidelines aim to break the cycle
Science Dailytech

Heart disease and kidney disease can fuel each other. New guidelines aim to break the cycle

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBOTzlpc2RDcXFkck90UGhjdmtNTkZ0RERYX2Z5NXFZa09aallBaWtVNEJXbmRyWHVROVNuUkZiVlRiNEVNaElWQXZkWWpzOEtoWXhCZGRkd3V3YnZlenFoaElHRExKSC02ajM4ZjFvQQ?oc=5" target="_blank">Heart disease and kidney disease can fuel each other. New guidelines aim to break the cycle</a>  <font color="#6f6f6f">Science Daily</font>

Read Full StoryMore like this
New guidelines recommend all patients with heart disease are tested for kidney disease
Medical Xpressgeneral

New guidelines recommend all patients with heart disease are tested for kidney disease

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQYWc0d2l5SWxqcWg1YkNEOWlVeFFNX2hLc2JCRHVYRmNVMzZCSThidzhZVkVCMTlvdU9PcEFYdmZQWU0yWTZpUVZVSE1FYnFMbGNHLWFFSVY5TFFINjNBdlpHV2dCR211c0IxU2ljUnJ4TTZ6QWNLaFJlWkU5bU1UVW9aajdZZVEzWmR6SQ?oc=5" target="_blank">New guidelines recommend all patients with heart disease are tested for kidney disease</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
First joint guidelines address cardiovascular events and chronic kidney disease
News-Medicalgeneral

First joint guidelines address cardiovascular events and chronic kidney disease

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNRTV1S193UTAyV3RyNEtHcFB6VzE5UWRZWHkwOTdQY0ZPc3QyMVJiTEhhZ0lEaHZ5MXFWc25sWEEwdlc1N1o4QzRIX25uaHRCeUtfOU0zRmc2TFd5QlIwZnRfTE1vWUJRM21YSXRrTXpDVjJiYXhNMmsxTkp1SVZQSnh2RDZXdW9ZeWo3SDNzWXpMYXBxbzRPRnVjZzhkY24zRmF0NF9Vd3FzTjBwTEdLQTZsZU56VWFZS1pFMlBZQUtVZm9Xd1E?oc=5" target="_blank">First joint guidelines address cardiovascular events and chronic kidney disease</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
The therapeutic approach to cardiovascular–kidney–metabolic syndrome
Naturegeneral

The therapeutic approach to cardiovascular–kidney–metabolic syndrome

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5VR01hYnJuaFVIUWpFUlg3T0NzZ2l6alJ1VElSMlk2YkNaaWlnRGZ3ZXVNbnkxYlV1VFNkTGFGeTR0eU1CVGJtdjhRc2hiM1dCUm1Ra1RVUjRKdlk4dGN3?oc=5" target="_blank">The therapeutic approach to cardiovascular–kidney–metabolic syndrome</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
professional.heart.orggeneral

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPdmpUSnZpbzl3NjJKRHBUOXU2dWIxdlFoQWVRNVNpQlRUQ1MwempMTXRvR2lETHNTa192VkxGWEI1TjFFX3RLUTFXRXFSOFpOeWFia0VHRFFwVmViRm1JTHg2QzBVdXg3RmR6YnktWWJLaS1HUmZQZDBEN280WDFPc0I3M2VvTnJRT1g0Uk1QNDJrSFF6eUZaVVNaSnpvc25PeXlUdE5GRkJLNjJTSnNMaWxFaXY1dEM0OE1KRWpFREpqTWdHS3ZieGpvTHU?oc=5" target="_blank">2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome</a>  <font color="#6f6f6f">professional.heart.org</font>

Read Full StoryMore like this
Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions
American Heart Association Journalsgeneral

Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTFBGQVp3MGFoY3NLcm11TmNTUXpwQXYxSGotOXE3RTlYbmtmNkdNdlVMTktNMUVHNjdtSm1qbEFwZWFNQ0ZHRXJEV1FiOTBfdGh6T1RnYnFUZ21FclhsLWsyS1RpNTJnVzNuMndDcUY0bw?oc=5" target="_blank">Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney Interactions</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies
Frontiersgeneral

Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPeUQ1c3hQVjhLNTBFc1BVQjIyb3BQVnhnZWx2NHBCSDZuaTVkdGdUVlZaOVNJeU5vcHZ5bnZBdHp2UUhCWmVsYnU2UGFnRE9PRzE4VmRxNTBLU0ZFLU41SjQyWnlXV2RGR0daWmpUcUdQejgzNFZfWGp4OWt6azF1dzMyMUo5OHhBSEFSU1hxVUVnampLZGc?oc=5" target="_blank">Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes
Naturetech

Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBiQ2wybXA3SlVMRmt4enZNRHVxWk0zdVBvWll3LXplWW9FXy1xdHhDSkdoQ3VlMUhTTjUzN1dmTkJRaC1Nb1g1ckRpcVBGdTRkQTZ0ME5xX1haR21Sdk9B?oc=5" target="_blank">Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Uncovering core diseases in temporal trajectories of cardiovascular-kidney-metabolic (CKM) syndrome in UK Biobank: network-based study
Naturemarkets

Uncovering core diseases in temporal trajectories of cardiovascular-kidney-metabolic (CKM) syndrome in UK Biobank: network-based study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1LX2M1NVdfYVl0dUNLSVZHYVJscHk4a1YzRHUzb1ZyMndnaXZvY056UU5OZkZ4ZGsxQ3g5Q0NPUGxPRnhhYWlVbVdRN2F0cFpXVFRiVERXak5zUlRiQ0VF?oc=5" target="_blank">Uncovering core diseases in temporal trajectories of cardiovascular-kidney-metabolic (CKM) syndrome in UK Biobank: network-based study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
New guideline reframes weight as health risk tied to diabetes, kidney and heart conditions
www.heart.orgscience

New guideline reframes weight as health risk tied to diabetes, kidney and heart conditions

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNb0VqSzNfN1ROb21GN0JwbGxGb0toOWU4Y1BoXzlCaU1FTXRYd0cwa2pSTXNjbGV6SjNzd1JLbTV3S1ZKemg2cVo4b1ZJQXpFZ3JOTVZZQWVNdHJxT2RsZWVtbmhFbHRnTnI2VTJIdzQ2YWlOVTdOMUE0aU9WYnVuODZDbUkzS3BibEMtVENsVWdUbk5ZZWpWZ3Z1UTFOV3VFOXdYekllS3Zoa1JWMEt0TklBSDNVS2NxNHFPS3dR?oc=5" target="_blank">New guideline reframes weight as health risk tied to diabetes, kidney and heart conditions</a>  <font color="#6f6f6f">www.heart.org</font>

Read Full StoryMore like this
Preeclampsia as an early manifestation of cardiovascular–kidney–metabolic syndrome
Frontiersgeneral

Preeclampsia as an early manifestation of cardiovascular–kidney–metabolic syndrome

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNWGhlRVpXQTNiVURHRkFWZnVuQXpMRmp0QXZ4bjNBaVFwRTF1YVo4bkc0RVFpTGJpNld6aU81ZW1BZUFhNTJqSzBrYTROVDBlVG8tblFDMjdiaXlWWjFLWWlUZG93b04tcFo1RVNISHlVbVBrWTNDaVd3UnlWVlFGVkpkOHZiTnV2c2RydTRVVWd4Zw?oc=5" target="_blank">Preeclampsia as an early manifestation of cardiovascular–kidney–metabolic syndrome</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis
The Lancetgeneral

Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPNWJPYmVsVW40ZkVhakxRTkxTV0hscHh5T2ZlT2paOWYwdEhUeGR5YXpLYUo4bHpMcDZsYXZSa1NTckNoVExJYUJHOGZFa0RVV1hGYXhSTmlwcnJCZVA3MW45LWZCb2R3WTlVcGtvRjNuMVV0MnpKV1Y5MGJaSmwybURpRUJlODRnTGJZ?oc=5" target="_blank">Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits
The Lancetgeneral

GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNUktFelBLS0Etd1RrSkhxT0hZZmUzS0RkdVNSQXFhYThzNUE4TGdKU245QmhxZVlfX1FkYWRfRU9WcVpWSUFrdmlYWnhrbTB3NW1KdVRSLVUwVVg3SktkeEhrRk8xWGRLTWY4SWowekN4M0RwdnBtRTlVdE5QU0pXUGs4Vk5zUk9yd3Nz?oc=5" target="_blank">GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome
Naturegeneral

A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9pRTJHdnU4N195ZlNnSHgzbFE4NE1hOFAzaXdGckhPdlN2SE5JOWFQZ3N3T29iSDRYeEI1Uk9VTlcxc1RjMHdma2J0MDdvRGJ4UVpFTVBBcHBNM0xFX1BN?oc=5" target="_blank">A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
The Effect of Empagliflozin on Renal Outcomes in Patients With Established Cardiovascular Disease: Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials
Wiley Online Librarygeneral

The Effect of Empagliflozin on Renal Outcomes in Patients With Established Cardiovascular Disease: Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBKWThpcmpNaUFkVkRveEdHcVctRUxSOERBck03S3ZMMnMydUp2NGFkNUpVWW1vVnJyb3hmbUZ0Vjlvck5TNmR1NWdBd3VJcjFkMXVyUUs2VUt5UTBIOW9mWndxSy1McVNzS3Rv?oc=5" target="_blank">The Effect of Empagliflozin on Renal Outcomes in Patients With Established Cardiovascular Disease: Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials</a>  <font color="#6f6f6f">Wiley Online Library</font>

Read Full StoryMore like this
Incretin analogues as cardiovascular agents: a state-of-the-art review
Frontiersgeneral

Incretin analogues as cardiovascular agents: a state-of-the-art review

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNUEdEQ1ZfQk05Zk45bnhiVmxjTzNrMnlYVUN2RXZOYmlTdG5mdzBqaWpvX25pNWRvWXFjYkNySVp1ZFExY0FQMmhLSVlxcExFdFRDQkF0WkJNQ2s4cTM3WXQ1RjFTZjQtVXQ2ZDR5TDI4dVJuRnZfLUMyZmdKc1lmVDRzd3ZSRHc0OWJJdXVrVFZMTm1PZkE?oc=5" target="_blank">Incretin analogues as cardiovascular agents: a state-of-the-art review</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Cardiovascular risk assessed using the SCORE system and blood renalase concentration in the Polish subpopulation of the PURE study
Naturegeneral

Cardiovascular risk assessed using the SCORE system and blood renalase concentration in the Polish subpopulation of the PURE study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9HcThYbmRTTWtMcUtEcXBtdFJPZ055NWlMVWlZUWRVSU1CY0piRVdVeTZlMUc3V2R1RWhoMDJTemZDbDhuc1lCU1NMUEdfdzFSNGtBTWtremZ5cjlUVzVn?oc=5" target="_blank">Cardiovascular risk assessed using the SCORE system and blood renalase concentration in the Polish subpopulation of the PURE study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome
American Heart Association Journalsgeneral

uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome

<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBnZzFYMHZhZHI3NDhmV0pfZ0lGTml3b0d5ZVVDMzRNMFNmLWVESXpuQkl1cjRneVNMajZMSnMydVIwVkFEVE9naEhhbTNqU1Z2VnMxNU1yUHNVSmlGY1kzcE44aTJoWVZjQUFuVkdB?oc=5" target="_blank">uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension
American Heart Association Journalsgeneral

Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9zN2RlYzQ5R21KTUI4bXpEaTMyQTJta28yQmtLZEVmNWc4cnRtbXgwMVdOOEdyWXJNSWVoSmVwcmlvYmNhTEVLcWVvWVgyTFlTcTlqcHpNR2hLT2FaSG10cVhGU2xDVDY3YlBJRm54TG9HVWs?oc=5" target="_blank">Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial | Hypertension</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Cardiovascular benefit of blood-pressure lowering in chronic kidney disease
The Lancetgeneral

Cardiovascular benefit of blood-pressure lowering in chronic kidney disease

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQa1NLUjhna3NCQlkyQ1VUb0lRdDY5Szc0N0x5UWlqRmIwTEwxSk42RGFTbW9jVjlJbXdST0ZpSXJvUG1NUVR5a1dya3MySV81b1VTLUlVMHRLWFduMFItTUM5dFFqak5kX1MyNDROcmpGdFdTRFRRTmNFRjVrVDcxUVM1UzhpUkRCVzRwSEo0Ynh1RlNRNXc?oc=5" target="_blank">Cardiovascular benefit of blood-pressure lowering in chronic kidney disease</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Retinal Microvascular Disease in Diabetes and Its Prognostic Utility for Cardiovascular and Renal Complications: A Comprehensive Literature Review
Cureusgeneral

Retinal Microvascular Disease in Diabetes and Its Prognostic Utility for Cardiovascular and Renal Complications: A Comprehensive Literature Review

<a href="https://news.google.com/rss/articles/CBMikgJBVV95cUxQbnJ3RXktTWdNbGhISU1wY29lb1B0OERxSDdnSC1hRTdPZ2NnOWxNUU5yLXZDSUNrRzBzWnkxRU83R0EtNVNISGJVQ2hpQXYtUWdiTXd1Q1BQQWM1N0FXYUVVY1F1NmZYZmJDY3dRUmIzMnYzWTBOYWZGREkzRjJtc2YzQTVKZE5CRERaMlM5NkJKRUg1LXB0WTUwMGRxaVE0UG52ZGhxdFRQLUM0d25UU2xaNF9EcFROVmlUb2R5MjJ5bTM4WFh2aGN0S1lFU3VGUExFamxMak52STdHVHRRT2FWQmZyckpyWTdsSXc2QkREWmRibEFET0hLX1QwMXhkNHZJcDB0X2ZWeFd4NDA4aWhR?oc=5" target="_blank">Retinal Microvascular Disease in Diabetes and Its Prognostic Utility for Cardiovascular and Renal Complications: A Comprehensive Literature Review</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
"Cardiovascular and Renal" — Live Google News Trends & Headlines